A Comparative In Vitro Sensitivity Study of "Ceftriaxone-Sulbactam-EDTA" and Various Antibiotics against Gram-negative Bacterial Isolates from Intensive Care Unit.
Singh S, Sahu C, Patel SS, Singh A, Yaduvanshi N.
Singh S, et al. Among authors: sahu c.
Indian J Crit Care Med. 2020 Dec;24(12):1213-1217. doi: 10.5005/jp-journals-10071-23573.
Indian J Crit Care Med. 2020.
PMID: 33446975
Free PMC article.
Hence, in light of present study, we strongly recommend inclusion of CSE in routine sensitivity panel and may be used as a carbapenem- and colistin-sparing drug and a promising option against ESBL and MBL producers especially in ICU. HOW TO CITE THIS ARTICLE: Singh S, Sahu …
Hence, in light of present study, we strongly recommend inclusion of CSE in routine sensitivity panel and may be used as a carbapenem- and c …